![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 21, 18497-18506, May 25, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From The wild type p53 tumor suppressor protein is
rapidly degraded in normal cells by MDM2, the ubiquitin ligase that
serves as the key regulator of p53 function by modulating protein
stability. Cellular exposure to genotoxic stress triggers the
stabilization of p53 by multiple pathways that converge upon
interference with MDM2 function. In this study, we first investigated
the ability of HDM2 (MDM2 human homologue) to degrade endogenous p53 in
neuroblastoma (NB). Although the p53 protein in NB has been reported to
be constitutively stabilized, we find that HDM2 in NB is functional and
facilitates the rapid turnover of p53 in nonstressed cells via the
proteasome pathway. Second, we examined the relationship between p53
and HDM2 in the adriamycin-mediated stabilization of p53 in NB. We demonstrate that while p53 stabilization depends neither upon the
phosphorylation of specific N-terminal sites nor upon dissociation from
HDM2, it requires inactivation of functional HDM2. In support of this
notion, p53 stabilization following adriamycin resulted in an
inhibition of both p53 ubiquitination and HDM2 ligase activity. Taken
together, these data implicate a requirement for enzymatic inactivation
of HDM2 as a novel mechanism for p53 stabilization in the DNA damage
response pathway.
Requirement for HDM2 Activity in the Rapid Degradation
of p53 in Neuroblastoma*
,
¶
Tumor Cell Biology Section, Medicine
Branch, NCI, National Institutes of Health, Rockville, Maryland 20850 and the § Laboratory of Cell Biology, NCI, National
Institutes of Health, Bethesda, Maryland 20892-1152
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
J.-H. Lee, M.-W. Jeong, W. Kim, Y. H. Choi, and K.-T. Kim Cooperative Roles of c-Abl and Cdk5 in Regulation of p53 in Response to Oxidative Stress J. Biol. Chem., July 11, 2008; 283(28): 19826 - 19835. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Lee, H.-S. Kim, S.-J. Lee, and K.-T. Kim Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death J. Cell Sci., July 1, 2007; 120(13): 2259 - 2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barbieri, P. Mehta, Z. Chen, L. Zhang, A. Slack, S. Berg, and J. M. Shohet MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death. Mol. Cancer Ther., September 1, 2006; 5(9): 2358 - 2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Koblish, S. Zhao, C. F. Franks, R. R. Donatelli, R. M. Tominovich, L. V. LaFrance, K. A. Leonard, J. M. Gushue, D. J. Parks, R. R. Calvo, et al. Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo Mol. Cancer Ther., January 1, 2006; 5(1): 160 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Saville, A. Sparks, D. P. Xirodimas, J. Wardrop, L. F. Stevenson, J.-C. Bourdon, Y. L. Woods, and D. P. Lane Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo J. Biol. Chem., October 1, 2004; 279(40): 42169 - 42181. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.'i. Saito, X.-F. Liu, K. Kamijo, R. Raziuddin, T. Tatsumoto, I. Okamoto, X. Chen, C.-C. Lee, M. V. Lorenzi, N. Ohara, et al. Deregulation and Mislocalization of the Cytokinesis Regulator ECT2 Activate the Rho Signaling Pathways Leading to Malignant Transformation J. Biol. Chem., February 20, 2004; 279(8): 7169 - 7179. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Kiat, K. M. Hui, and G. Gopalan Aurora-A Kinase Interacting Protein (AIP), a Novel Negative Regulator of Human Aurora-A Kinase J. Biol. Chem., November 15, 2002; 277(47): 45558 - 45565. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.'i. Saito, A. A. Goodarzi, Y. Higashimoto, Y. Noda, S. P. Lees-Miller, E. Appella, and C. W. Anderson ATM Mediates Phosphorylation at Multiple p53 Sites, Including Ser46, in Response to Ionizing Radiation J. Biol. Chem., April 5, 2002; 277(15): 12491 - 12494. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |